These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31796489)

  • 1. Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study.
    Thinn KK; Thekkur P; Kyaw NTT; Aye NS; Zaw TM; Soan P; Hone S; Oo HN
    BMJ Open; 2019 Dec; 9(12):e032678. PubMed ID: 31796489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near point-of-care HIV viral load testing: Cascade after high viral load in suburban Yangon, Myanmar.
    Tun NN; Smithuis F; Tun NL; Min M; Hlaing MMM; Olmen JV; Lynen L; Gils T
    PLoS One; 2023; 18(4):e0272673. PubMed ID: 37053171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
    Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
    AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provision of HIV viral load testing services in Zimbabwe: Secondary data analyses using data from health facilities using the electronic Patient Monitoring System.
    Apollo T; Takarinda KC; Phillips A; Ndhlovu C; Cowan FM
    PLoS One; 2021; 16(1):e0245720. PubMed ID: 33481931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and Outcomes of Routine Viral Load Testing in People Living with HIV Newly Initiating ART in the Integrated HIV Care Program in Myanmar between January 2016 and December 2017.
    Ya SST; Harries AD; Wai KT; Kyaw NTT; Aung TK; Moe J; Htun T; Shin HN; Aye MM; Oo HN
    Trop Med Infect Dis; 2020 Aug; 5(3):. PubMed ID: 32878307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    Kamble S; Shidhaye P; Mukherjee A; Tak M; Bembalkar S; Aggarwal S; Deb A; Kapoor N; Verma V; Das C; Kulkarni S; Ghate M; Godbole S
    PLoS One; 2023; 18(5):e0285942. PubMed ID: 37200292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.
    Ochodo EA; Olwanda EE; Deeks JJ; Mallett S
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013208. PubMed ID: 35266555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis.
    Mesic A; Spina A; Mar HT; Thit P; Decroo T; Lenglet A; Thandar MP; Thwe TT; Kyaw AA; Homan T; Sangma M; Kremer R; Grieg J; Piriou E; Ritmeijer K; Van Olmen J; Lynen L; Oo HN
    AIDS Res Ther; 2021 Apr; 18(1):16. PubMed ID: 33882962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia.
    Teeraananchai S; Law M; Boettiger D; Mata N; Gupte N; Chan YL; Pham TN; Chaiwarith R; Ly PS; Chan YJ; Kiertiburanakul S; Khusuwan S; Zhang F; Yunihastuti E; Kumarasamy N; Pujari S; Azwa I; Somia IKA; Tanuma J; Ditangco R; Choi JY; Ng OT; Do CD; Gani Y; Ross J; Jiamsakul A;
    J Int AIDS Soc; 2022 Aug; 25(8):e25989. PubMed ID: 36028921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
    Msimango L; Gibbs A; Shozi H; Ngobese H; Humphries H; Drain PK; Garrett N; Dorward J
    BMC Health Serv Res; 2020 Nov; 20(1):1081. PubMed ID: 33239012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India.
    Laxmeshwar C; Acharya S; Das M; Keskar P; Pazare A; Ingole N; Mehta P; Gori P; Mansoor H; Kalon S; Singh P; Mathur T; Ferlazzo G; Isaakidis P
    PLoS One; 2020; 15(5):e0232576. PubMed ID: 32369504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead - a systematic review.
    Pham MD; Nguyen HV; Anderson D; Crowe S; Luchters S
    BMC Public Health; 2022 Jun; 22(1):1203. PubMed ID: 35710413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
    Bvochora T; Satyanarayana S; Takarinda KC; Bara H; Chonzi P; Komtenza B; Duri C; Apollo T
    PLoS One; 2019; 14(2):e0211326. PubMed ID: 30721229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to viral load testing guidelines, barriers, and associated factors among persons living with HIV on ART in Southwestern Uganda: a mixed-methods study.
    Lubega P; Nalugya SJ; Kimuli AN; Twinokusiima M; Khasalamwa M; Kyomugisa R; Kabami J; Owaraganise A
    BMC Public Health; 2022 Jun; 22(1):1268. PubMed ID: 35768800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.
    Rutstein SE; Golin CE; Wheeler SB; Kamwendo D; Hosseinipour MC; Weinberger M; Miller WC; Biddle AK; Soko A; Mkandawire M; Mwenda R; Sarr A; Gupta S; Mataya R
    AIDS Care; 2016; 28(1):1-10. PubMed ID: 26278724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021.
    Tomescu S; Crompton T; Adebayo J; Akpan F; Dauda DS; Allen Z; Ondura EO; Wose Kinge C; Chasela C; Pisa P
    BMJ Open; 2023 May; 13(5):e065950. PubMed ID: 37169497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar.
    Thiha N; Chinnakali P; Harries AD; Shwe M; Balathandan TP; Thein Than Tun S; Das M; Tin HH; Yi Y; Babin FX; Lwin TT; Clevenbergh PA
    PLoS One; 2016; 11(8):e0160616. PubMed ID: 27505228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Journey towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs.
    Swannet S; Decroo T; de Castro SMTL; Rose C; Giuliani R; Molfino L; Torrens AW; Macueia WSED; Perry S; Reid T
    Int Health; 2017 Jul; 9(4):206-214. PubMed ID: 28810670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
    Kahabuka MS; Woldeamanuel Y; Mbelele PM; Mpolya EA; Mpagama SG; Kessy JP; Manyazewal T
    BMC Infect Dis; 2024 Apr; 24(1):390. PubMed ID: 38605325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.